The company had a very short period of time to announce a new Chairman and Director to comply with the listing rules.
It makes sense that they lookined internally to do so, and the CFO is a suitable candidate.
I have no doubt that the non-exec they end up appointing will have suitable skills and experience, and given the trial results are only weeks away the ability to attract a high calibre person as a non-exec will significantly increase very soon.
I like todays announcement. It mentions that Steve is there to lead through the commercialisation process, which is signalling that there is a product to commercialise... ie the Phase III results will be ok.
Time to raid the piggy bank again me thinks. This company is way too cheap
EMS Price at posting:
2.9¢ Sentiment: None Disclosure: Held